Here’s How You can Prevent Diabetic Kidney Disease

Diabetic nephropathy can be prevented by blocking the activation of the epidermal growth factor receptor (EGFR) with drug Erlotinib.

Highlights

Cancer drug aids in preventing diabetic kidney disease
Blocking epidermal growth factor receptor (EGFR) with drug Erlotinib helps prevent diabetic nephropathy

Diabetic nephropathy (DN), a leading cause of kidney failure in the world can be prevented by blocking the activation of the epidermal growth factor receptor (EGFR) with the help of drug Erlotinib, reveals a new study.//

Diabetic kidney disease or DN leads to loss of kidney function in patients with diabetes and eventually kidney failure requiring kidney replacement therapy in form of dialysis or kidney transplantation.

Diabetic Kidney Disease - Symptoms, Signs, Causes, Diagnosis, Stages & Treatment
Diabetic nephropathy refers to kidney damage due very high levels of blood sugar levels in diabetics.

‘Diabetic nephropathy is a leading cause of kidney failure in the world. New research shows that blocking the activation of the epidermal growth factor receptor (EGFR) by drug Erlotinib may help prevent this devastating condition.’
Read More..

Epidermal Growth Factor Receptor (EGFR)

In an animal model, it has been shown that progression of diabetes type 1 is related to activation of the epidermal growth factor receptor (EGFR) and its inhibition can lead to prevention of development of kidney disease.

Epidermal growth factor receptor (EGFR) has been in the news because Stanley Cohen, Ph.D., shared the Nobel Prize in medicine in 1986 for this discovery.

Benefits of Proteome Analysis for Detection of Diabetic Nephropathy Remains Unclear
Proteome analysis is a new diagnostic method in which the concentration of several biomarkers in the urine is determined by means of mass spectrometry.

EGFR protein can become active when phosphate molecules get attached at specific tyrosine sites in the protein. The phosphorylated tyrosines then become active docking sites for a variety of molecules that regulate cell proliferation, maturation, and cell death.

In a study published in the journal Diabetes, Harris, Ming-Zhi Zhang, MD, and colleagues have shown that by blocking the EGFR tyrosine kinase activity with the drug erlotinib, it is possible to slow the progression of diabetic kidney disease of nephropathy.

Inflammation in Diabetic Nephropathy may be Reduced by Chromium Picolinate
Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy, a new study has concluded.

It also helps in decreasing insulin resistance and stops weight gain. Using this pathway of blocking EGFR may be an attractive method to treat this condition.

Facts and Statistics about Diabetic Nephropathy

Low Blood Oxygenation Associated With Impaired Kidney Function and Diabetic Nephropathy
Hypoxemia also called as low oxygen desaturation is defined as an abnormally-low partial pressure of oxygen in the arterial blood.

Diabetes accounts for about 44 percent of new cases of kidney failure

More than 35 percent of people aged 20 years or older with diabetes have chronic kidney disease

Prediabetes can damage the kidneys. However, making changes to your diet and exercising daily can make a big difference in preventing type 2 diabetes and protecting the kidneys

Tips to Prevent Diabetic Nephropathy
Diabetic nephropathy can be prevented by following few simple tips.

Keeping your blood sugar under control

Maintaining healthy weight

Eating healthy

Exercising regularly

Taking the required medications regularly

Source-Medindia